Biotechnology & Synthetic BiologyUpdated Aug 20, 2026Version v1
Reviewed milestones, validation shifts, standards, datasets, and debates linked to public evidence.
Evidence from Molecules indicates that GANs are increasingly used in drug design and discovery. This is tracked as a clinical because it changes how Generative protein design is understood, validated, or applied.
Evidence from Proteins: Structure, Function, and Bioinformatics indicates that Machine learning is crucial for predicting protein function due to experimental limitations. This is tracked as a review because it changes how Generative protein design is understood, validated, or applied.
Evidence from Current Opinion in Chemical Biology indicates that Machine learning can improve protein sequence generation by leveraging prior knowledge. This is tracked as a review because it changes how Generative protein design is understood, validated, or applied. It is supported by 3 papers in the same timeline signal.
Evidence from Bioinformatics indicates that ProteoGAN outperforms existing deep-learning baselines for protein sequence generation. This is tracked as a breakthrough because it changes how Generative protein design is understood, validated, or applied.
Evidence from Protein Science indicates that Inverting AF2 with a loss function can bias sequences towards a target fold. This is tracked as a clinical because it changes how Generative protein design is understood, validated, or applied.
Evidence from Science indicates that Successfully designed and characterized novel transmembrane β-barrel pores. This is tracked as a breakthrough because it changes how Generative protein design is understood, validated, or applied.
Evidence from Journal of AI-Driven Communication Engineering indicates that AI-driven inverse design is transforming materials discovery by enabling computational exploration of novel materials with predefined properties. This is tracked as a review because it changes how Generative protein design is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.
Evidence from Advanced Intelligent Systems indicates that AI-guided de novo protein design can generate novel structural building blocks beyond natural constraints. This is tracked as a review because it changes how Generative protein design is understood, validated, or applied.
Evidence from Nature Communications indicates that The model performs state-of-the-art prediction of missense and indel effects without relying on evolutionary information. This is tracked as a method because it changes how Generative protein design is understood, validated, or applied.
Evidence from the accepted evidence indicates that Global context is crucial for accurate amino acid selection in protein design. This is tracked as a breakthrough because it changes how Generative protein design is understood, validated, or applied.
Evidence from Molecular Systems Biology indicates that AlphaDesign enables rapid generation and computational validation of proteins. This is tracked as a breakthrough because it changes how Generative protein design is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.
Evidence from Journal of cheminformatics indicates that No single generative model demonstrated overall dominance across all evaluation criteria. This is tracked as a standard because it changes how Generative protein design is understood, validated, or applied.